Why the study?
Does agomelatine improve mental status and quality of life in patients with acute coronary syndrome?
Does agomelatine improve mental status and quality of life in patients with acute coronary syndrome?
The addition of agomelatine to standard therapy for acute coronary syndrome may improve mental status and quality of life in patients with anxiety and depression.
Supports adjunctive agomelatine for mental status and QoL in ACS; extends evidence to acute coronary settings.
Continuous sampling method using aquestionnaireHospitalAnxiety and Depression Scale (GSHTD) held survey 250 patients with acute coronary syndrome (ACS) admitted to the emergency Department of cardiologyInstituteofCardiology, SB of RAMS. Of these, 85 people (34%) were detected symptoms of anxiety and depression in 165 people (66%), anxiety and depressive symptoms were found. In a pilot randomized prospective comparative study included 46 people. Against the background of the basic treatment of ACS, 23 patients received an additional agomelatine. Results of the study are showed an improvement in mental status and quality of life
No takes yet. Share an insight, caveat, or question.
Попонина et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: